03 April 2025
: Case report 
A Rare Case of Ovarian Serous Borderline Tumor Recurrence with Muscle Metastasis
Unusual clinical course
Akitoshi Yamamura
1BCDEF, Mana Taki1ABDE*, Sachiko Kitamura1B, Masumi Sunada1B, Koji Yamanoi1DE, Ryusuke Murakami1EF, Takayoshi Shimizu2AB, Ken Yamaguchi 1EFG, Junzo Hamanishi 1DEF, Sachiko Minamiguchi 3BC, Masaki Mandai1A
DOI: 10.12659/AJCR.946680
Am J Case Rep 2025; 26:e946680
Table 1. Report of the recurrence rate and time to recurrence of SBT.
| Author | Stage (n) | Recurrence rate | Time to recurrence | Follow-up period (year) |
|---|---|---|---|---|
| Silva et al, (2006)[]23 | Stage II: 29Stage III: 50Stage IV: 1 | 44% (35/80) | <5 y: 10% (8/80) 5 to 10 y: 18.8% (15/80) 10 to 15 y: 10% (8/80) >15 y: 5% (4/80) | 5 to 31 (median 15.7) |
| Baba et al, (2023) []12 | Stage I: 250Stage II–IV: 39 | 4.2% (12/289) | 10-year PFS: 92.3% | No data available |
| Song et al, (2012) []24 | Stage I: 71 | 9.9% (7/71) | 0.8 to 6.2 y (median 3.2) | 1 to 13 (median 4.7) |
| Gilks et al, (2003) []25 | Stage II: 15Stage III: 34 | 28.6% (14/49) | 1 to 8 y (mean 3.5) | 3 to 18 (median 6) |